Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Syntrix Pharmaceuticals
Sort By
Newest First
Sign in
1 / 1
1 / 1
Immunotherapy
Researchers Report SX-682 Could Enhance Multiple Forms of T Cell-Based Immunotherapies in Solid Tumors
Syntrix Pharmaceuticals
PR-M04-19-NI-040
Apr 11, 2019
